Followers | 835 |
Posts | 32904 |
Boards Moderated | 12 |
Alias Born | 03/22/2016 |
Friday, April 12, 2024 10:00:08 AM
Recent RANI News
- Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist • GlobeNewswire Inc. • 10/17/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 10:06:59 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/16/2024 10:04:38 AM
- Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants • GlobeNewswire Inc. • 10/15/2024 12:30:00 PM
- Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit • GlobeNewswire Inc. • 10/08/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 08:10:35 PM
- Rani Therapeutics to Participate in September Investor Conferences • GlobeNewswire Inc. • 09/03/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:09:34 PM
- Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:04:18 PM
- Rani Therapeutics to Participate in August Investor Conferences • GlobeNewswire Inc. • 07/29/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 10:06:57 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/23/2024 10:05:12 AM
- Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering • GlobeNewswire Inc. • 07/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 09:19:32 PM
- Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:03:53 PM
- Rani Therapeutics to Participate in May Investor Conferences • GlobeNewswire Inc. • 05/14/2024 12:00:00 PM
- Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024 • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:09:53 PM
- Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 05/06/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:04:34 PM
- Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 03/20/2024 08:05:00 PM
- Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/15/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 01:10:21 PM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM